BE705035A - - Google Patents
Info
- Publication number
- BE705035A BE705035A BE705035DA BE705035A BE 705035 A BE705035 A BE 705035A BE 705035D A BE705035D A BE 705035DA BE 705035 A BE705035 A BE 705035A
- Authority
- BE
- Belgium
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/643—Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases RNAses, DNAses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB45695/66A GB1136039A (en) | 1966-10-12 | 1966-10-12 | Improvements relating to immunosuppressive agents |
Publications (1)
Publication Number | Publication Date |
---|---|
BE705035A true BE705035A (fr) | 1968-04-12 |
Family
ID=10438194
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE705035D BE705035A (fr) | 1966-10-12 | 1967-10-12 |
Country Status (6)
Country | Link |
---|---|
AT (1) | AT275037B (fr) |
BE (1) | BE705035A (fr) |
ES (1) | ES345979A1 (fr) |
FR (2) | FR1552939A (fr) |
GB (1) | GB1136039A (fr) |
NL (1) | NL6713800A (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4043869A (en) | 1972-07-13 | 1977-08-23 | Koch-Light Laboratories, Ltd. | Water insoluble biologically active material |
DK3063275T3 (da) * | 2013-10-31 | 2019-11-25 | Resolve Therapeutics Llc | Terapeutiske nuklease-albumin-fusioner og fremgangsmåder |
-
1966
- 1966-10-12 GB GB45695/66A patent/GB1136039A/en not_active Expired
-
1967
- 1967-10-11 FR FR1552939D patent/FR1552939A/fr not_active Expired
- 1967-10-11 FR FR124050A patent/FR7058M/fr not_active Expired
- 1967-10-11 NL NL6713800A patent/NL6713800A/xx unknown
- 1967-10-11 ES ES345979A patent/ES345979A1/es not_active Expired
- 1967-10-12 AT AT926367A patent/AT275037B/de active
- 1967-10-12 BE BE705035D patent/BE705035A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
ES345979A1 (es) | 1968-12-01 |
GB1136039A (en) | 1968-12-11 |
NL6713800A (fr) | 1968-04-16 |
FR7058M (fr) | 1969-06-23 |
AT275037B (de) | 1969-10-10 |
FR1552939A (fr) | 1969-01-10 |